A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
